Join CHES Foundation, Girls Bleed Too and HEMAB
May 6, 2026

If you or someone you love has Von Willebrand Disease, there's something new on the horizon. A company called Hemab Therapeutics is studying a medicine called HMB-002, a simple shot given under the skin that's designed to help your body hold onto more of the von willebrand factor it needs. 

Join Tara O'Meara and Henry Mead from Hemab as they explain how HMB-002 works, what the VELORA studies involve, and how you or a family member might be able to take part. 

Tara O'Meara, SVP, Development Operations.  Tara has spent over 20+ years running global clinical trials and will walk you through what to expect if you're thinking about joining the Velora studies. 

Henry Mead, Medical Science Liaison. Henry has been part of the bleeding disorders community for over 20 years. He gets the day-to-day reality of living with VWD and has a knack for breaking down the science in a way that actually makes sense. 

WEBINAR: Discover a New Investigational Approach to VWD Treatment 

Wednesday May 6,
2026 - 8pm EST

Zoom Session shared with all who sign-up